Thursday, Apr 25 2024 | Time 15:34 Hrs(IST)
image
Business Economy


NCCN Announces Beth Gaffney, MBA, as New Vice President of U.S. and Global Business Development

New executive will lead the National Comprehensive Cancer Network's programs for sharing evidence- and expert consensus-based resources to improve cancer care.
PLYMOUTH MEETING, Pennsylvania, Oct. 27, 2020 /PRNewswire/ -- The National Comprehensive Cancer Network®(NCCN®) today announced the addition of Beth Gaffney, MBA, as the new Vice President of U.S. and Global Business Development. In this role, Gaffney oversees both U.S. and global business activities and the development of the NCCN brand worldwide. She will work closely with other members of the NCCN senior leadership team to ensure the influence of NCCN content and the ongoing collaboration and support of all of our stakeholders. Gaffney will lead multiple functional areas across the organization, including business development (U.S. and global), business insights, commercial licensing, health information technology, and payer and employer outreach. She will also work in conjunction with NCCN's marketing and communications department and oncology policy program.
Gaffney is a graduate of The Wharton School of the University of Pennsylvania with more than 15 years of strategic business development and marketing experience in the healthcare industry, most recently serving as head of business development for risk management and patient support services for United Biosource Corporation. Prior to that she held positions with Johnson & Johnson's McNeil Consumer Healthcare division and Men's Health Magazine.
"We couldn't be happier about having Beth join us for this critical business development role," said Robert W. Carlson, MD, Chief Executive Officer, NCCN. "Beth's strong leadership and biotech knowledge, combined with a lifelong passion for helping people achieve better health, make her an excellent fit as our new Vice President of U.S. and Global Business Development. She will be a leading voice for our important collaborations across the oncology ecosystem worldwide."
"I am thrilled to have the opportunity to join NCCN," said Gaffney. "To be a part of the NCCN team dedicated to improving cancer care so that patients can live better lives is truly an honor. I look forward to leading Business Development and joining the effort to further advance NCCN's mission globally."
Gaffney will join NCCN on October 27, 2020.
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centersdevoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, efficient, and accessible cancer care so patients can live better lives. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) provide transparent, evidence-based, expert consensus recommendations for cancer treatment, prevention, and supportive services; they are the recognized standard for clinical direction and policy in cancer management and the most thorough and frequently-updated clinical practice guidelines available in any area of medicine. The NCCN Guidelines for Patients® provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation®. NCCN also advances continuing education, global initiatives, policy, and research collaboration and publication in oncology. Visit NCCN.org for more information and follow NCCN on Facebook @NCCNorg, Instagram @NCCNorg, and Twitter @NCCN.
Media Contact:
Rachel Darwin
267-622-6624
[email protected]
Logo - https://mma.prnewswire.com/media/441768/NCCN_Logo.jpg
(Disclaimer--Features may vary depending on the regions; subject to change without notice.)
More News
Dr Reddy’s Lab and Nestlé India enter into definitive agreement to form JV company

Dr Reddy’s Lab and Nestlé India enter into definitive agreement to form JV company

25 Apr 2024 | 2:40 PM

Hyderabad, April 25 (UNI) Dr. Reddy’s Laboratories and Nestlé India have entered into a definitive agreement to form a joint venture company to bring innovative nutraceutical brands to consumers in India and other agreed territories.

see more..
SBI General Insurance records 17 pc growth in topline and a profit growth of 30 pc in FY 23-24

SBI General Insurance records 17 pc growth in topline and a profit growth of 30 pc in FY 23-24

25 Apr 2024 | 2:18 PM

Kolkata, Apr 25 (UNI) SBI General Insurance announced its financial results for FY 23-24, recording 17 per cent growth in topline faster than market growth and a profit growth of 30 per cent in FY 23-24.

see more..
Tata Motors accelerates innovation: record 222 patents filed and 333 grants secured in FY24

Tata Motors accelerates innovation: record 222 patents filed and 333 grants secured in FY24

25 Apr 2024 | 1:10 PM

Hyderabad, Apr 25 (UNI) Part of the USD 150 billion Tata group, Tata Motors Limited, India’s leading automobile company, has yet again achieved a significant milestone towards intellectual property rights (IPR) creation with a record-breaking number of 222 Patents and 117 designs applications filed during the year FY24, highest in its history.

see more..

RITES collaborates with DVC for rail infra works

25 Apr 2024 | 1:05 PM

Mumbai, April 25 (UNI) RITES Ltd., a prime transport infrastructure consultancy on Thursday said that it has signed an MoU with Damodar Valley Corporation (DVC), a statutory body under the Ministry of Power, to collaborate for Project Management Consultancy for rail infra works.

see more..

JioCinema to redefine subscription market with launch of Premium Plans

25 Apr 2024 | 12:42 PM

Mumbai, April 25 (UNI) JioCinema, the video streaming platform of Reliance Industries, has rolled out new subscription plans, JioCinema Premium, which will include ad-free content across languages, including original series, movies, children's shows, and TV entertainment on any device, including connected TV sets, for Rs 29 a month.

see more..
image